In this study, using a synthetic lethal approach, we identified a candidate compound NSC84167, termed as NRF2 synthetic lethal compound-01, NSLC01, which is selectively toxic to PDAC cancer cells and PDX tumors with high NRF2 activation. The gene discussed is NFE2L2; the disease is cancer.